Evidence map›Paper›PMID 27524450›Full record

ReviewClinics in perinatology2016

Inflammatory Biomarkers of Birth Asphyxia.

Lina F Chalak

Abstract readReview
In one paragraph

Review in Clinics in perinatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lina F ChalakDepartment of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Room F3.312B, Dallas, TX 75390-9063, USA. Electronic address: Lina.chalak@utsouthwestern.edu.

Funding

Cerebrovascular Dysfunction in Newborns with HIE during Hypothermia and RewarmingK23HD069521 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI CHALAK, LINA F · 2012 to 2014
$368k
NICHD NIH HHS K23 HD069521
6 · The paper itself

Abstract

Although therapies in addition to whole-body cooling are being developed to treat the neonate at risk for hypoxic-ischemic encephalopathy, we have no quickly measured serum inflammatory or neuronal biomarkers to acutely and accurately identify brain injury or to follow the efficacy of therapy. This review covers inflammatory serum biomarkers in the setting of birth asphyxia that can help assess the degree or severity of encephalopathy at birth and neurodevelopmental outcomes. These biomarkers still need to be independently validated in large cohorts before they are ready for clinical implementation in practice.

Indexed as

Asphyxia NeonatorumBiomarkersCytokinesFemaleGlial Fibrillary Acidic ProteinHumansHypoxia-Ischemia, BrainInfant, NewbornInflammationPhosphopyruvate HydratasePlacentaPregnancyS100 Calcium Binding Protein beta SubunitUbiquitin ThiolesteraseBiomarkersCytokinesGlial Fibrillary Acidic ProteinPhosphopyruvate HydrataseS100B protein, humanS100 Calcium Binding Protein beta SubunitUbiquitin carboxyl-Terminal Hydrolase L-1, humanUbiquitin ThiolesteraseAsphyxiaCytokinesGFAPPlacentaUbiquitin

Identifiers

PMID27524450
PMCPMC6170165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.